Annual Accounts Receivable
$18.66 M
-$15.28 M-45.02%
31 December 2023
Summary:
BioLife Solutions annual accounts receivable is currently $18.66 million, with the most recent change of -$15.28 million (-45.02%) on 31 December 2023. During the last 3 years, it has risen by +$10.65 million (+133.04%). BLFS annual accounts receivable is now -45.02% below its all-time high of $33.94 million, reached on 31 December 2022.BLFS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$17.92 M
-$146.00 K-0.81%
30 September 2024
Summary:
BioLife Solutions quarterly accounts receivable is currently $17.92 million, with the most recent change of -$146.00 thousand (-0.81%) on 30 September 2024. Over the past year, it has dropped by -$6.64 million (-27.03%). BLFS quarterly accounts receivable is now -47.20% below its all-time high of $33.94 million, reached on 31 December 2022.BLFS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.0% | -27.0% |
| 3 y3 years | +133.0% | -11.4% |
| 5 y5 years | +512.7% | +315.4% |
BLFS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.0% | +133.0% | -47.2% | at low |
| 5 y | 5 years | -45.0% | +512.7% | -47.2% | +315.4% |
| alltime | all time | -45.0% | >+9999.0% | -47.2% | >+9999.0% |
BioLife Solutions Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $17.92 M(-0.8%) |
| June 2024 | - | $18.06 M(-2.7%) |
| Mar 2024 | - | $18.57 M(-0.4%) |
| Dec 2023 | $18.66 M(-45.0%) | $18.66 M(-24.0%) |
| Sept 2023 | - | $24.56 M(-8.6%) |
| June 2023 | - | $26.86 M(-11.5%) |
| Mar 2023 | - | $30.34 M(-10.6%) |
| Dec 2022 | $33.94 M(+46.2%) | $33.94 M(+4.6%) |
| Sept 2022 | - | $32.44 M(+3.8%) |
| June 2022 | - | $31.26 M(+28.8%) |
| Mar 2022 | - | $24.27 M(+4.5%) |
| Dec 2021 | $23.22 M(+190.0%) | $23.22 M(+14.8%) |
| Sept 2021 | - | $20.23 M(-4.1%) |
| June 2021 | - | $21.09 M(+97.7%) |
| Mar 2021 | - | $10.67 M(+33.3%) |
| Dec 2020 | $8.01 M(+49.8%) | $8.01 M(+31.4%) |
| Sept 2020 | - | $6.09 M(+40.1%) |
| June 2020 | - | $4.35 M(-47.0%) |
| Mar 2020 | - | $8.21 M(+53.5%) |
| Dec 2019 | $5.34 M(+75.5%) | $5.34 M(+23.9%) |
| Sept 2019 | - | $4.31 M(+12.6%) |
| June 2019 | - | $3.83 M(+30.9%) |
| Mar 2019 | - | $2.93 M(-3.9%) |
| Dec 2018 | $3.04 M(+198.2%) | $3.04 M(+12.8%) |
| Sept 2018 | - | $2.70 M(+24.6%) |
| June 2018 | - | $2.17 M(+107.5%) |
| Mar 2018 | - | $1.04 M(+2.2%) |
| Dec 2017 | $1.02 M(-14.5%) | $1.02 M(-24.7%) |
| Sept 2017 | - | $1.36 M(+15.5%) |
| June 2017 | - | $1.17 M(+10.6%) |
| Mar 2017 | - | $1.06 M(-11.1%) |
| Dec 2016 | $1.19 M(+28.4%) | $1.19 M(-9.0%) |
| Sept 2016 | - | $1.31 M(+2.1%) |
| June 2016 | - | $1.28 M(+7.9%) |
| Mar 2016 | - | $1.19 M(+28.1%) |
| Dec 2015 | $929.30 K(+3.1%) | $929.30 K(+17.3%) |
| Sept 2015 | - | $792.30 K(-2.1%) |
| June 2015 | - | $809.40 K(-4.9%) |
| Mar 2015 | - | $851.00 K(-5.6%) |
| Dec 2014 | $901.60 K(-10.7%) | $901.60 K(+16.3%) |
| Sept 2014 | - | $775.10 K(+36.8%) |
| June 2014 | - | $566.50 K(-57.3%) |
| Mar 2014 | - | $1.33 M(+31.3%) |
| Dec 2013 | $1.01 M(+68.2%) | $1.01 M(-1.7%) |
| Sept 2013 | - | $1.03 M(+4.7%) |
| June 2013 | - | $981.00 K(+0.5%) |
| Mar 2013 | - | $976.20 K(+62.6%) |
| Dec 2012 | $600.20 K | $600.20 K(-24.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $797.90 K(+122.1%) |
| June 2012 | - | $359.20 K(-23.9%) |
| Mar 2012 | - | $471.80 K(-13.8%) |
| Dec 2011 | $547.10 K(+61.4%) | $547.10 K(+19.3%) |
| Sept 2011 | - | $458.70 K(+16.0%) |
| June 2011 | - | $395.30 K(+10.8%) |
| Mar 2011 | - | $356.70 K(+5.3%) |
| Dec 2010 | $338.90 K(+7.5%) | $338.90 K(+6.9%) |
| Sept 2010 | - | $317.10 K(+11.2%) |
| June 2010 | - | $285.20 K(-20.5%) |
| Mar 2010 | - | $358.80 K(+13.8%) |
| Dec 2009 | $315.40 K(+13.0%) | $315.40 K(-14.6%) |
| Sept 2009 | - | $369.30 K(+85.4%) |
| June 2009 | - | $199.20 K(-18.7%) |
| Mar 2009 | - | $245.00 K(-12.2%) |
| Dec 2008 | $279.20 K(-7.1%) | $279.20 K(-22.9%) |
| Sept 2008 | - | $362.10 K(+58.2%) |
| June 2008 | - | $228.90 K(+6.6%) |
| Mar 2008 | - | $214.80 K(-28.5%) |
| Dec 2007 | $300.50 K(+203.5%) | $300.50 K(+43.1%) |
| Sept 2007 | - | $210.00 K(+20.2%) |
| June 2007 | - | $174.70 K(+17.0%) |
| Mar 2007 | - | $149.30 K(+50.8%) |
| Dec 2006 | $99.00 K(+29.8%) | $99.00 K(+69.8%) |
| Sept 2006 | - | $58.30 K(-49.0%) |
| June 2006 | - | $114.30 K(+37.7%) |
| Mar 2006 | - | $83.00 K(+8.8%) |
| Dec 2005 | $76.30 K(+1.3%) | $76.30 K(+41.0%) |
| Sept 2005 | - | $54.10 K(+32.6%) |
| June 2005 | - | $40.80 K(-25.3%) |
| Mar 2005 | - | $54.60 K(-27.5%) |
| Dec 2004 | $75.30 K(+115.8%) | $75.30 K(-34.9%) |
| Sept 2004 | - | $115.70 K(+9.9%) |
| June 2004 | - | $105.30 K(+30.3%) |
| Mar 2004 | - | $80.80 K(+131.5%) |
| Dec 2003 | $34.90 K(-21.9%) | $34.90 K(-48.2%) |
| Sept 2003 | - | $67.40 K(-12.6%) |
| June 2003 | - | $77.10 K(+8.9%) |
| Mar 2003 | - | $70.80 K(+58.4%) |
| Dec 2002 | $44.70 K(-17.2%) | $44.70 K(+2529.4%) |
| Sept 2002 | - | $1700.00(0.0%) |
| June 2002 | - | $1700.00(-96.4%) |
| Mar 2002 | - | $46.90 K(-13.1%) |
| Dec 2001 | $54.00 K(-37.9%) | $54.00 K(-62.7%) |
| Sept 2001 | - | $144.90 K(-15.5%) |
| June 2001 | - | $171.50 K(-59.3%) |
| Mar 2001 | - | $420.90 K(+383.8%) |
| Dec 2000 | $87.00 K(-64.7%) | $87.00 K |
| Dec 1999 | $246.40 K | - |
FAQ
- What is BioLife Solutions annual accounts receivable?
- What is the all time high annual accounts receivable for BioLife Solutions?
- What is BioLife Solutions annual accounts receivable year-on-year change?
- What is BioLife Solutions quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for BioLife Solutions?
- What is BioLife Solutions quarterly accounts receivable year-on-year change?
What is BioLife Solutions annual accounts receivable?
The current annual accounts receivable of BLFS is $18.66 M
What is the all time high annual accounts receivable for BioLife Solutions?
BioLife Solutions all-time high annual accounts receivable is $33.94 M
What is BioLife Solutions annual accounts receivable year-on-year change?
Over the past year, BLFS annual accounts receivable has changed by -$15.28 M (-45.02%)
What is BioLife Solutions quarterly accounts receivable?
The current quarterly accounts receivable of BLFS is $17.92 M
What is the all time high quarterly accounts receivable for BioLife Solutions?
BioLife Solutions all-time high quarterly accounts receivable is $33.94 M
What is BioLife Solutions quarterly accounts receivable year-on-year change?
Over the past year, BLFS quarterly accounts receivable has changed by -$6.64 M (-27.03%)